Craft

Advanced
GNTbm

GNTbm

Stock Price

NT$37.5

2024-10-29

Market Capitalization

NT$1.6 B

2024-10-28

Revenue

NT$1.7 M

FY, 2024

GNTbm Summary

Company Summary

Overview
GNTbm (Great Novel Therapeutics Biotech & Medicals, 華上生技醫藥股份有限公司) is a company that focuses on drug development for cancer treatment. It offers chidamide, tumor immunotherapy, epigenetic immune modulators, etc.
Type
Public
Status
Active
Founded
2013
HQ
Taipei, TW | view all locations
Website
https://www.gntbm.com.tw/index_en.php
Cybersecurity rating
Sectors

Table of Contents

LocationsView all

1 location detected

  • Taipei, Taipei City HQ

    Taiwan

    16f 5, No. 508, Section 7, Zhongxiao E Rd

GNTbm Financials

Summary Financials

Revenue (H1, 2025)
NT$623.0K
Gross profit (H1, 2025)
NT$388.0K
Net income (H1, 2025)
(NT$44.8M)
Cash (H1, 2025)
NT$187.6M
EBIT (H1, 2025)
(NT$48.6M)
Enterprise value
$1.5B

Competitors and Similar Companies

Compare competitors

Footer menu

Product

Solutions

Resources

Company

© Craft.co 2026
Share price data provided by IEX